BRANDES INVESTMENT PARTNERS, LP - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$103,000
-19.5%
34,8280.0%0.00%
-33.3%
Q2 2018$128,000
+4.9%
34,8280.0%0.00%0.0%
Q1 2018$122,000
+11.9%
34,8280.0%0.00%
+50.0%
Q4 2017$109,000
-55.5%
34,8280.0%0.00%
-60.0%
Q3 2017$245,000
-23.7%
34,8280.0%0.01%0.0%
Q2 2017$321,000
-14.2%
34,8280.0%0.01%
-16.7%
Q1 2017$374,000
+15.1%
34,828
-9.7%
0.01%
+20.0%
Q4 2016$325,00038,5820.01%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 1,800,000$1,404,0002.63%
Stonepine Capital Management, LLC 491,096$383,0000.26%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 918,342$716,0000.05%
KNOTT DAVID M 109,135$85,0000.04%
EdgePoint Investment Group Inc. 2,831,555$2,209,0000.02%
Yakira Capital Management, Inc. 36,428$28,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$36,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 85,409$66,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 37,717$29,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders